NCT05202899 2022-03-09
Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake Craniotomy
Guangzhou General Hospital of Guangzhou Military Command
Phase 4 Unknown
Clinical Trials
4 trialsNCT03996655 2019-06-25
Different Reversal Agents in Pediatric Day-case Cancer Surgery
National Cancer Institute, Egypt
Phase 4 Unknown
NCT03728543 2018-11-02
the Efficacy and Safety of Sugammadex in Children 0-2 Years Old
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 2/3 Unknown
NCT02944175 2018-10-19
Cerebral Oxygenation and Metabolism After Reversal Of Rocuronium: Comparison Between Sugammadex Versus Neostigmine
Mansoura University
Phase NA Unknown